Brand Description Back  
At Cephalon, they never lose sight of why they're in business: to improve health and enhance the quality of the lives of patients through smart application of science.

Founded in 1987 as a biotech start-up, Cephalon have grown into one of the world's top ten biopharmaceutical companies, with an impressive roster of first-in-class products, a deep and diverse pipeline

Cephalon's portfolio of innovative treatments for central nervous system disorders, pain, cancer and addiction include nine proprietary products in the United States, along with more than 30 products internationally. Cephalon's research pipeline is focused on developing new compounds and new indications for existing products, while their business collaborations capitalize on new products and smart drug delivery technologies.